We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Mayne Pharma Group Limited is a drug manufacturers-general business based in Australia. Mayne Pharma Group shares (MYX) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Mayne Pharma Group has a trailing 12-month revenue of around $438.7 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Mayne Pharma Group
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Mayne Pharma Group. Find the share by name or ticker symbol: MYX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Mayne Pharma Group reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Mayne Pharma Group. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
Mayne Pharma Group share priceUse our graph to track the performance of MYX stocks over time.
Mayne Pharma Group shares at a glance
|52-week range||$0.275 - $0.515|
|50-day moving average||$0.379|
|200-day moving average||$0.3617|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.19|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Mayne Pharma Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Mayne Pharma Group price performance over time
|1 week (2021-06-15)||1.35%|
|1 month (2021-05-21)||0.375|
|3 months (2021-03-22)||5.63%|
|6 months (2020-12-22)||7.14%|
|1 year (2020-06-22)||-1.32%|
|2 years (2019-06-21)||-26.47%|
|3 years (2018-06-22)||-55.62%|
|5 years (2016-06-22)||-74.68%|
Is Mayne Pharma Group under- or over-valued?
Valuing Mayne Pharma Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mayne Pharma Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Mayne Pharma Group's EBITDA
Mayne Pharma Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $60.4 million.
The EBITDA is a measure of a Mayne Pharma Group's overall financial performance and is widely used to measure a its profitability.
Mayne Pharma Group financials
|Revenue TTM||$438.7 million|
|Gross profit TTM||$211.5 million|
|Return on assets TTM||-0.42%|
|Return on equity TTM||-27.47%|
|Market capitalisation||$617.7 million|
TTM: trailing 12 months
Mayne Pharma Group share dividends
We're not expecting Mayne Pharma Group to pay a dividend over the next 12 months.
Mayne Pharma Group share price volatility
Over the last 12 months, Mayne Pharma Group's shares have ranged in value from as little as $0.275 up to $0.515. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Mayne Pharma Group's is 0.838. This would suggest that Mayne Pharma Group's shares are less volatile than average (for this exchange).
Mayne Pharma Group overview
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, the United States, Korea, and internationally. The company operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. It also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Frequently asked questions
More guides on Finder
Prime Day VR gaming deal: $60 off the Oculus Quest 2
Amazon is selling the standalone Oculus Quest 2 virtual-reality headset for $432.12. You can also score $77 off the 256GB version.
Scott Pape’s Money Movement: How to watch the docu-series online in Australia
This fresh docu-series features the one and only Barefoot Investor.
Prime Day’s best health and fitness deals: Garmin, FitBit, PranaOn
Stocking up on your favourite supplements or adding to your home gym, Amazon has got you covered with these red-hot offers.
Amazon Prime Day’s best camera deals: Nikon, Panasonic and more
DSLR, digital, polaroids, lenses and accessories - these are the best camera deals Amazon has to offer this Prime Day.
Biggest Amazon Prime Day discounts: 75% off games + heaps more
Top offers so far include 75% off games, 68% off tech and 38% off alcohol.
Jetstar sale offers new route to “Australia’s most beautiful coastlines”
You have to be quick, these fares are gone with the strike of midnight.
Kobo Elipsa review: An eReader and eNote 2-in-1
The Kobo Elipsa makes a valiant attempt to bridge the gap between eReader and eNote. It doesn’t manage to excel at being one or the other as its big for an eReader, and slow for an eNote.
Amazon Prime Day: Best board game offers on Hasbro, MONOPOLY, Jenga
From children to teens and adults, Amazon has got you covered with these awesome board game deals.
Amazon Prime Day: Red-hot fashion deals on Bonds, Champion and more
Fashionistas can score sweet savings on Skechers shoes, Bonds everyday essentials and winter warmers from Champion.
Why has the Zip Co share price run out of steam?
Shares in BNPL provider Zip Co have jumped over 16% in the last month.
Ask an Expert